Wash U Awarded $6.5M Grant to Develop Sequencing-Based Breast Cancer Vaccine
April 19, 2011
Wash U Awarded $6.5M Grant to Develop Sequencing-Based Breast Cancer Vaccine
"Identification and validation of mutations in individual breast cancers provides an unprecedented opportunity to target unique tumor antigens with personalized breast cancer vaccines," the researchers wrote in their project abstract.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Wash U Team Aims to Develop Sequencing-Based Individualized Vaccines for Breast Cancers
April 26, 2011 / Clinical Sequencing News - Wash U Team Looks to Expand on Initial Success of Sequencing in Breast Cancer Clinical Trial
April 5, 2011 / Clinical Sequencing News - Sequencing Studies Lead to New Clinical Trial for Overlooked HER2 Mutations in Breast Cancer
December 12, 2012 / Clinical Sequencing News - New Products
May 24, 2011 / Clinical Sequencing News - Sequencing Guides Cancer Treatment, but Illustrates Need for Regulatory and Ethical Framework
April 26, 2011 / Clinical Sequencing News